Clinical Trial Update: Multimodality Risk Adapted Tx Including Induction Chemo for SCCHN Amenable to Transoral Surgery [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating multimodality, risk-adapted treatment that includes induction chemotherapy for squamous cell carcinoma of the head and neck am…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Squamous Cell Carcinoma of the Head and Neck

Snippet

Sponsor: UNC Lineberger Comprehensive Cancer Center | Conditions: Head and Neck Cancer, Squamous Cell Carcinoma of the Head and Neck | Phase 2 | Status: COMPLETED | Results posted: 2017-10-13